Trial
NCT01147601
Topical Timolol 0.5% Solution for Proliferating Infantile Hemangiomas
Early Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Oregon Health and Science University
Collaborators
—
Condition
Hemangioma
Intervention
topical 0.5% Timolol
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-07-05